ICU Medical (ICUI) Tops Q2 EPS Views; Boosts FY15 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
ICU Medical, Inc. Announces Second Quarter 2015 Results
August 10, 2015 4:02 PM EDTSAN CLEMENTE, Calif., Aug. 10, 2015 (GLOBE NEWSWIRE) -- ICU Medical, Inc., (Nasdaq: ICUI) ("ICU Medical"), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy, oncology and critical care applications, today announced financial results for the second quarter ended June 30, 2015.
Second Quarter 2015 Results
Second quarter 2015 revenue was $83.8 million, compared to $78.7 million in the same period last year. GAAP net income for the second quarter of 2015 was $13.6 million, or $0.83 per diluted share, as compared to GAAP net income of $5.9 million, or $0.38 per... More
